Previous studies have shown that rutin can improve diabetes by inhibiting the activities of α-glucosidase and α-amylase [31,32], activating the synthesis of transporter GLUT-4 [33], increasing the expression of PPARγ [28], reducing hepatic G6Pase [34], and increasing hexokinase activity [33]. Here, SLC2A4 is linked to diabetes mellitus.